CompletedNCT00725920
Topiramate or placebo for PTSD
About this title
Placebo Controled Clinical Trial Using Topiramate To Treat Posttraumatic Stress Disorder (PTSD) Patients.
Read the official source — NCT00725920Medication studyAges 18–65Brazil
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- São PauloSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateJanuary 2007
- Recruitment status
- Completed
- Enrollment listed in the registry
- 35
- Sponsor
- Federal University of São Paulo
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Brazil
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00725920
- Official title
Show the full official title
Randomized Clinical Trial to Study the Topiramate Efficacy for Posttraumatic Disorder Treatment
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
São Paulo
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Federal University of São Paulo, a university.
Did this study involve medication?
Yes. The study involved medication, including Topiramate and placebo control group.
Who was this study for?
Listed age limits: 18 years to 65 years.
